1542743-74-7

Basic information

• Product Name: (R)-2-((9-oxo-9H-xanthen-3-yl)oxy)-N-(1-(p-tolyl)ethyl)acetamide
• Synonyms: (R)-2-((9-oxo-9H-xanthen-3-yl)oxy)-N-(1-(p-tolyl)ethyl)acetamide
• CAS NO: 1542743-74-7
• Molecular Weight: 387.435
• Mol File: 1542743-74-7.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: (R)-2-((9-oxo-9H-xanthen-3-yl)oxy)-N-(1-(p-tolyl)ethyl)acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-2-((9-oxo-9H-xanthen-3-yl)oxy)-N-(1-(p-tolyl)ethyl)acetamide(1542743-74-7)
• EPA Substance Registry System: (R)-2-((9-oxo-9H-xanthen-3-yl)oxy)-N-(1-(p-tolyl)ethyl)acetamide(1542743-74-7)

Safety Data

• Hazardous Substances Data: 1542743-74-7(Hazardous Substances Data)

Upstream product

• 25363-95-5 <(9-oxoxanthen-3-yl)oxy>acetic acid 
• 42070-98-4 1-(p-tolyl)ethylamine 
• 62495-36-7 (2-hydroxy-4-methoxyphenyl)(2-methoxyphenyl)methanone 
• 1542744-03-5 methyl 2-((9-oxo-9H-xanthen-3-yl)oxy)acetate 
• 3722-51-8 3-hydroxyxanthen-9-one 
• 3722-52-9 3-methoxyxanthone 
• 586-70-9 (R)-4'-methyl-1-phenylethylamine 
• 151-10-0 1,3-Dimethoxybenzene 
• 21615-34-9 2-Methoxybenzoyl chloride 

Relevant articles and documents

Enantiomeric resolution and docking studies of chiral xanthonic derivatives on chirobiotic columns

A systematic study of enantioresolution of a library of xanthonic derivatives, prepared “in-house”, was successfully carried out with four commercially available macrocyclic glycopeptide-based columns, namely ChirobioticTM T, ChirobioticTM R, ChirobioticTM V and ChirobioticTM TAG. Evaluation was conducted in multimodal elution conditions: normal-phase, polar organic, polar ionic and reversed-phase. The effects of the mobile phase composition, the percentage of organic modifier, the pH of the mobile phase, the nature and concentration of different mobile phase additives on the chromatographic parameters are discussed. ChirobioticTM T and ChirobioticTM V, under normal-phase and reversed-phase modes, respectively, presented the best chromatographic parameters. Considering the importance of understanding the chiral recognition mechanisms associated with the chromatographic enantioresolution, and the scarce data available for macrocyclic glycopeptide-based columns, computational studies by molecular docking were also carried out.

New chiral stationary phases based on xanthone derivatives for liquid chromatography

Six chiral derivatives of xanthones (CDXs) were covalently bonded to silica, yielding the corresponding xanthonic chiral stationary phases (XCSPs). The new XCSPs were packed into stainless-steel columns with 150 x 4.6 mm i.d. Moreover, the greening of the chromatographic analysis by reducing the internal diameter (150 x 2.1 mm i.d.) of the liquid chromatography (LC) columns was also investigated. The enantioselective capability of these phases was evaluated by LC using different chemical classes of chiral compounds, including several types of drugs. A library of CDXs was evaluated in order to explore the principle of reciprocity as well as the chiral self-recognition phenomenon. The separation of enantiomeric mixtures of CDXs was investigated under multimodal elution conditions. The XCSPs provided high specificity for the enantiomeric mixtures of CDXs evaluated mainly under normal-phase elution conditions. Furthermore, two XCSPs were prepared with both enantiomers of the same xanthonic selector in order to confirm the inversion order elution.